Rethinking therapeutic decisions for hepatitis B infection in Syria: insights into molecular monitoring
Introduction: Hepatitis B virus patients are usually treated in Syria with alpha interferon and nucleos(t)ide analogues. Genotypic viral factors causing inadequate response or relapse following initial response are not routinely investigated. This study aimed to explore and discuss local therapeutic...
Saved in:
| Main Authors: | Wafa Habbal, Fawza Monem |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Journal of Infection in Developing Countries
2012-10-01
|
| Series: | Journal of Infection in Developing Countries |
| Subjects: | |
| Online Access: | https://jidc.org/index.php/journal/article/view/2596 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SEROPOSITIVITY OF HEPATITIS B AND C AMONG SYRIAN MULTITRANSFUSED PATIENTS WITH HEMOGLOBINOPATHY
by: Widad Yazaji, et al.
Published: (2016-09-01) -
Brucellosis laboratory tests in Syria: what are their diagnostic efficacies in different clinical manifestations?
by: Yara Alsayed, et al.
Published: (2012-05-01) -
Prevalence of "anti-HBc alone" among Syrian blood donors
by: Wael Muselmani, et al.
Published: (2014-08-01) -
EBV Plasma Epstein-Barr Virus (EBV) DNA as a Biomarker for Diagnosis of EBV-positive Hodgkin Lymphoma in Syria
by: Rana Habeeb, et al.
Published: (2021-12-01) -
Case of Fatal Hepatitis Related to HEV-3 Infection in Central Italy
by: Monica Borghi, et al.
Published: (2024-11-01)